
Bicara Therapeutics Inc. Common Stock
USD29.21
-0.13 (-0.44%)
CEO
Claire Mazumdar Clemon
IPO Date
2024-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$29.51
Prev. Close
$29.34
Day Low
$28.99
Day High
$29.82
52W Low
$8.74
52W High
$29.82
Market Cap
$1.60B
Volume
0.81M
| 31 Mar 2026 |
| Citizens |
| Market Outperform |
| Market Outperform |
| maintain |
| 31 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 31 Mar 2026 | Goldman Sachs | Neutral | Neutral | maintain |
| 31 Mar 2026 | Wells Fargo | Equal Weight | Equal Weight | maintain |
| 13 Jan 2026 | Wedbush | Outperform | Outperform | maintain |
| 11 Nov 2025 | Wells Fargo | Equal Weight | Equal Weight | maintain |
| 22 Aug 2025 | HC Wainwright & Co. | Buy | Buy | maintain |